Urinary insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2) are increasingly recognized as the best markers of developing AKI in septic patients. This evidence concerns the gene TIMP2 and acute kidney injury.